Related references
Note: Only part of the references are listed.The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
Nurul Hakimah Mohd Salim et al.
BIOMEDICINES (2023)
Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals
Atif Khurshid Wani et al.
VETERINARY RESEARCH COMMUNICATIONS (2023)
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
Friederike Christen et al.
LEUKEMIA (2022)
CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review
Nagaraj Bharathkumar et al.
MOLECULAR BIOTECHNOLOGY (2022)
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Si-Wei Wang et al.
MOLECULAR CANCER (2022)
Genome-wide functional screens enable the prediction of high activity CRISPR-Cas9 and-Cas12a guides in Yarrowia lipolytica
Dipankar Baisya et al.
NATURE COMMUNICATIONS (2022)
CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency
Vanessa S. Fear et al.
STEM CELL RESEARCH & THERAPY (2022)
Progress in cancer epidemiology: avoided deaths in Europe over the last three decades
Carlo La Vecchia et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2022)
Clinical Significance and Biological Function of miR-1274a in Non-small Cell Lung Cancer
Shi-jia Zhu et al.
MOLECULAR BIOTECHNOLOGY (2022)
miR-1251-5p Overexpression Inhibits Proliferation, Migration, and Immune Escape in Clear Cell Renal Cell Carcinoma by Targeting NPTX2
Lin Yue et al.
JOURNAL OF ONCOLOGY (2022)
Narrative on Hydrogen Therapy and its Clinical Applications: Safety and Efficacy
Aqeel Ahmad et al.
CURRENT PHARMACEUTICAL DESIGN (2022)
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
Jaitip Tipanee et al.
MOLECULAR THERAPY (2022)
Effectiveness of physical activity on immunity markers and quality of life in cancer patient: a systematic review
Sameer Badri Al-Mhanna et al.
PEERJ (2022)
Advance trends in targeting homology- directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR- Cas9 systems
Forough Shams et al.
BIOIMPACTS (2022)
SOX9 in organogenesis: shared and unique transcriptional functions
Zhenhua Ming et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study
Pouya Safarzadeh Kozani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Pourya Sarvari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
CRISPR/Cas9-mediated Gene Knockout Followed by Negative Selection Leads to a Complete TCR Depletion in orthoCAR19 T Cells
Qian Zhang et al.
BIO-PROTOCOL (2022)
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems
Forough Shams et al.
BIOIMPACTS (2022)
Inhibiting PDE7A Enhances the Protective Effects of Neural Stem Cells on Neurodegeneration and Memory Deficits in Sevoflurane-Exposed Mice
Yanfang Huang et al.
ENEURO (2021)
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases
Garima Sharma et al.
MOLECULAR THERAPY (2021)
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Georgina D. Barnabas et al.
CANCER RESEARCH (2021)
TT52CAR19: Phase 1 Trial of CRISPR/Cas9 Edited Allogeneic CAR19 T Cells for Paediatric Relapsed/Refractory B-ALL
Giorgio Ottaviano et al.
BLOOD (2021)
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Gabriel Pabst et al.
BLOOD (2021)
CRISPR technologies for precise epigenome editing
Muneaki Nakamura et al.
NATURE CELL BIOLOGY (2021)
Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids
Gayatri Ramakrishna et al.
HEPATOLOGY INTERNATIONAL (2021)
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Yongxian Hu et al.
CLINICAL CANCER RESEARCH (2021)
Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair
Colin L. Sweeney et al.
GENE THERAPY (2021)
A Comparison Between Organic and Inorganic Nanoparticles: Prime Nanoparticles for Tumor Curation
Bakhtawar Bukhari et al.
NANO (2021)
Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9
Ivan Pavlinov et al.
STEM CELL RESEARCH (2021)
CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells
Raviteja Inturi et al.
VIROLOGY (2021)
Inflammasome activation leads to cDC1-independent cross-priming of CD8 T cells by epithelial cell-derived antigen
Katherine A. Deets et al.
ELIFE (2021)
Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
Haohao Yin et al.
ACS CENTRAL SCIENCE (2021)
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
Zilong Zhou et al.
FRONTIERS IN ONCOLOGY (2021)
Interrogating immune cells and cancer with CRISPR-Cas9
Frank A. Buquicchio et al.
TRENDS IN IMMUNOLOGY (2021)
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Ehsan Razeghian et al.
STEM CELL RESEARCH & THERAPY (2021)
CRISPR-based diagnostics
Michael M. Kaminski et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Protocol A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids
Takuya Okamoto et al.
STAR PROTOCOLS (2021)
The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
Wei Lv et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Sasan Ghaffari et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma
Fei Li et al.
CANCER DISCOVERY (2020)
Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
Chenggong Li et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2020)
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
Rachael A. Vaubel et al.
CLINICAL CANCER RESEARCH (2020)
RNA-Targeting CRISPR-Cas Systems and Their Applications
Michal Burmistrz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CRISPR/Cas9 gene editing in a chicken model: current approaches and applications
Luiza Chojnacka-Puchta et al.
JOURNAL OF APPLIED GENETICS (2020)
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Dan Wang et al.
CELL (2020)
Long non-coding RNA in bladder cancer
Yuepeng Cao et al.
CLINICA CHIMICA ACTA (2020)
CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
Iraj Mohammadzadeh et al.
IUBMB LIFE (2020)
CRISPR-Cas9 system: A genome-editing tool with endless possibilities
Swati Tyagi et al.
JOURNAL OF BIOTECHNOLOGY (2020)
Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants
Mahmuda Binte Monsur et al.
GENES (2020)
CRISPR Tools To Control Gene Expression in Bacteria
Antoine Vigouroux et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2020)
AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
Ang Li et al.
MOLECULAR THERAPY (2020)
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Dan Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
CRISPR/Cas9-mediated mutation of OsSWEET14 in rice cv. Zhonghua11 confers resistance to Xanthomonas oryzae pv. oryzae without yield penalty
Xuan Zeng et al.
BMC PLANT BIOLOGY (2020)
CRISPR system: Discovery, development and off-target detection
Shengmiao Chen et al.
CELLULAR SIGNALLING (2020)
A Lactose-Derived CRISPR/Cas9 Delivery System for Efficient Genome Editing In Vivo to Treat Orthotopic Hepatocellular Carcinoma
Yu Qi et al.
ADVANCED SCIENCE (2020)
Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment
Xiaoling Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
Mohammadreza Azangou-Khyavy et al.
FRONTIERS IN IMMUNOLOGY (2020)
Clinical landscape of oncolytic virus research in 2020
Nicholas Macedo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A CRISPR-Cas9, Cre-lox, and Flp-FRT Cascade Strategy for the Precise and Efficient Integration of Exogenous DNA into Cellular Genomes
Jixue Li et al.
CRISPR JOURNAL (2020)
Efficient Correction of HAX1 Mutations in Primary HSPCs of Severe Congenital Neutropenia Patients Using CRISPR/CAS9 GENE-Editing
Malte U. Ritter et al.
BLOOD (2020)
CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges
Xing Chen et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2020)
Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
Wen-Di Pei et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2020)
SOCS2 affects the proliferation, migration, and invasion of nasopharyngeal carcinoma cells via regulating EphA1
B. Dai et al.
NEOPLASMA (2020)
Applying CRISPR/Cas13 to Construct Exosomal PD-L1 Ultrasensitive Biosensors for Dynamic Monitoring of Tumor Progression in Immunotherapy
Yi He et al.
ADVANCED THERAPEUTICS (2020)
Circulating microRNAs in oncogenic viral infections: potential diagnostic biomarkers
Kinza Hasham et al.
SN APPLIED SCIENCES (2020)
eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer
Shruthy Suresh et al.
NATURE CANCER (2020)
CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity
Ta Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy
Hong-yan Wu et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2019)
Applications and advances of CRISPR-Cas9 in cancer immunotherapy
An-Liang Xia et al.
JOURNAL OF MEDICAL GENETICS (2019)
Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research
Shuai Zhen et al.
HUMAN GENE THERAPY (2019)
Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9
Hong-Xia Zhang et al.
MOLECULAR THERAPY (2019)
CRISPR-Cas9 for cancer therapy: Opportunities and challenges
Minjiang Chen et al.
CANCER LETTERS (2019)
CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes
Haruna Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer
Chunyang Jiang et al.
TRENDS IN MOLECULAR MEDICINE (2019)
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids
Masayuki Fujii et al.
GASTROENTEROLOGY (2019)
Murine Models of Acute Myeloid Leukaemia
Marwa Almosailleakh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast
Magdalena Hryhorowicz et al.
MOLECULAR BIOTECHNOLOGY (2019)
Clinical applications of CRISPR-based genome editing and diagnostics
Dana V. Foss et al.
TRANSFUSION (2019)
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
Jun Wei et al.
NATURE (2019)
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Genome-Wide CRISPR Screening Identifies JAK1 Deficiency as a Mechanism of T-Cell Resistance
Ping Han et al.
FRONTIERS IN IMMUNOLOGY (2019)
Biomaterials as vectors for the delivery of CRISPR-Cas9
Joon Eoh et al.
BIOMATERIALS SCIENCE (2019)
CRISPR/Cas9 library screening for drug target discovery
Morito Kurata et al.
JOURNAL OF HUMAN GENETICS (2018)
P-130A phase I/II Trial of CRISPR-Cas9-mediated PD-1 knockout Epstein-Barr virus cytotoxic lymphocytes (EBV-CTLs) for advanced stage EBV associated malignancies - Trial in progress
J Wei et al.
ANNALS OF ONCOLOGY (2018)
Therapeutic applications of CRISPR/Cas9 system in gene therapy
Hasan Mollanoori et al.
BIOTECHNOLOGY LETTERS (2018)
Patient-derived organoid models help define personalized management of gastrointestinal cancer
M. R. Aberle et al.
BRITISH JOURNAL OF SURGERY (2018)
Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
Gulzar Ahmad et al.
DRUG DISCOVERY TODAY (2018)
History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
Yoshizumi Ishino et al.
JOURNAL OF BACTERIOLOGY (2018)
Long Terminal Repeat CRISPR-CAR-Coupled Universal T Cells Mediate Potent Anti-leukemic Effects
Christos Georgiadis et al.
MOLECULAR THERAPY (2018)
Mouse medulloblastoma driven by CRISPR activation of cellular Myc
BaoHan T. Vo et al.
SCIENTIFIC REPORTS (2018)
Excision of Nucleopolyhedrovirus Form Transgenic Silkworm Using the CRISPR/Cas9 System
Zhanqi Dong et al.
FRONTIERS IN MICROBIOLOGY (2018)
CRISPR/Cascade 9-Mediated Genome Editing-Challenges and Opportunities
Bhaskar Roy et al.
FRONTIERS IN GENETICS (2018)
CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
Xiaojun Liu et al.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2018)
Establishment of a baculovirus-inducible CRISPR/Cas9 system for antiviral research in transgenic silkworms
Zhanqi Dong et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
Hasan Mollanoori et al.
HUMAN IMMUNOLOGY (2018)
Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments
Michelle L. Kimberland et al.
JOURNAL OF BIOTECHNOLOGY (2018)
LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis
Jing Quan et al.
ONCOTARGETS AND THERAPY (2018)
Patient-derived organoids: a promising model for personalized cancer treatment
Huayu Yang et al.
GASTROENTEROLOGY REPORT (2018)
Recombinant Viruses for Cancer Therapy
Daria S. Chulpanova et al.
BIOMEDICINES (2018)
IDH2 Mutations Induce Altered STAT Signaling and Cytokine Responses Which Are Restored By Enasidenib
Kathryn S. Ivy et al.
BLOOD (2018)
Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resistance to IMiDs in Multiple Myeloma
Jiye Liu et al.
BLOOD (2018)
CRISPR-Cas9: a promising genetic engineering approach in cancer research
Zubair Ahmed Ratan et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine
Martin Kampmann
ACS CHEMICAL BIOLOGY (2018)
Generation of GGTA1 Mutant Pigs by Direct Pronuclear Microinjection of CRISPR/Cas9 Plasmid Vectors
Chin-Kai Chuang et al.
ANIMAL BIOTECHNOLOGY (2017)
CRISPR/Cas9: at the cutting edge of hepatology
Francis P. Pankowicz et al.
GUT (2017)
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
Jana Reimer et al.
HAEMATOLOGICA (2017)
Stem cell-derived organoids and their application for medical research and patient treatment
Sina Bartfeld et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
BIOTECHNOLOGY CRISPR fixes embryo error
Heidi Ledford
NATURE (2017)
BIOTECHNOLOGY CRISPR-Cas becoming more human
Kim Baumann
NATURE REVIEWS DRUG DISCOVERY (2017)
Essential Role of Sugar Transporter OsSWEET11 During the Early Stage of Rice Grain Filling
Lai Ma et al.
PLANT AND CELL PHYSIOLOGY (2017)
Generation of stable nulliplex autopolyploid lines of Arabidopsis thaliana using CRISPR/Cas9 genome editing
Peter Ryder et al.
PLANT CELL REPORTS (2017)
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers
Daniela Terracciano et al.
TRANSLATIONAL RESEARCH (2017)
microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma
Hirofumi Yoshino et al.
ONCOTARGET (2017)
CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice
Yongzhen Liu et al.
SCIENTIFIC REPORTS (2017)
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
Jana Reimer et al.
HAEMATOLOGICA (2017)
CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials
Leonhard Kick et al.
BIOENGINEERED (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Enhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 System
Ling Wang et al.
PLOS ONE (2017)
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia
Zuzana Tothova et al.
CELL STEM CELL (2017)
Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System
Yibei Xiao et al.
CELL (2017)
Translational applications of adult stem cell-derived organoids
Jarno Drost et al.
DEVELOPMENT (2017)
CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges
Lang Yi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
Tang Liu et al.
CANCER LETTERS (2016)
Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells
Jingjing Wang et al.
CANCER SCIENCE (2016)
Current Challenges in Cancer Treatment
Jon Zugazagoitia et al.
CLINICAL THERAPEUTICS (2016)
The discovery of CRISPR in archaea and bacteria
Francisco J. M. Mojica et al.
FEBS JOURNAL (2016)
The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans
Wei Li et al.
GENESIS (2016)
Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems
Ryan T. Leenay et al.
MOLECULAR CELL (2016)
Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference
Sanjay Ghosh et al.
NUCLEIC ACIDS RESEARCH (2016)
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
Yao Yuan et al.
ONCOLOGY REPORTS (2016)
CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
Ming Yuan et al.
VIRUSES-BASEL (2016)
Identification of a serum circulating IncRNA panel for the diagnosis and recurrence prediction of bladder cancer
Weili Duan et al.
ONCOTARGET (2016)
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
Julio Castano et al.
ONCOTARGET (2016)
CRISPR/Cas9 and cancer targets: future possibilities and present challenges
Martyn K. White et al.
ONCOTARGET (2016)
A CRISPR/Cas9 system adapted for gene editing in marine algae
Marianne Nymark et al.
SCIENTIFIC REPORTS (2016)
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
Wei-Jing Dai et al.
Molecular Therapy-Nucleic Acids (2016)
Deep Brain Photoreceptor (val-opsin) Gene Knockout Using CRISPR/Cas Affects Chorion Formation and Embryonic Hatching in the Zebrafish
Chong Yee Hang et al.
PLOS ONE (2016)
Targeted mutagenesis in chicken using CRISPR/Cas9 system
Isao Oishi et al.
SCIENTIFIC REPORTS (2016)
Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells
Chaolong Lin et al.
SCIENTIFIC REPORTS (2016)
Targeted Gene Knockin in Porcine Somatic Cells Using CRISPR/Cas Ribonucleoproteins
Ki-Eun Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer
M. Sachdeva et al.
CANCER GENE THERAPY (2015)
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
Justin S. LaFountaine et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
High-Efficiency Genome Editing in Arabidopsis Using YAO Promoter-Driven CRISPR/Cas9 System
Liuhua Yan et al.
MOLECULAR PLANT (2015)
Flexible guide-RNA design for CRISPR applications using Protospacer Workbench
Cameron Ross MacPherson et al.
NATURE BIOTECHNOLOGY (2015)
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
Isaac B. Hilton et al.
NATURE BIOTECHNOLOGY (2015)
Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids
Mami Matano et al.
NATURE MEDICINE (2015)
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
Pratiksha I. Thakore et al.
NATURE METHODS (2015)
A Cas9-guide RNA complex preorganized for target DNA recognition
Fuguo Jiang et al.
SCIENCE (2015)
A Generic Strategy for CRISPR-Cas9-mediated gene tagging
Daniel H. Lackner et al.
NATURE COMMUNICATIONS (2015)
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Marc Zuckermann et al.
NATURE COMMUNICATIONS (2015)
CRISPR validation of recessive brain cancer genes in vivo
Marc Zuckermann et al.
ONCOTARGET (2015)
ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
Simona Valletta et al.
ONCOTARGET (2015)
Precision cancer mouse models through genome editing with CRISPR-Cas9
Haiwei Mou et al.
GENOME MEDICINE (2015)
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
Tsui-Ting Ho et al.
NUCLEIC ACIDS RESEARCH (2015)
Multigene Knockout Utilizing Off-Target Mutations of the CRISPR/Cas9 System in Rice
Masaki Endo et al.
PLANT AND CELL PHYSIOLOGY (2015)
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
Hassen S. Wollebo et al.
PLOS ONE (2015)
CRISPR/Cas9-mediated knockout of factors in non-homologous end joining pathway enhances gene targeting in silkworm cells
Li Zhu et al.
SCIENTIFIC REPORTS (2015)
WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system
Nathan Wong et al.
GENOME BIOLOGY (2015)
CRISPR/Cas9-mediated genome engineering: An adeno-associated viral (AAV) vector toolbox
Elena Senis et al.
BIOTECHNOLOGY JOURNAL (2014)
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt et al.
CELL (2014)
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Hiroshi Nishimasu et al.
CELL (2014)
Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos
Yuyu Niu et al.
CELL (2014)
Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
Pankaj K. Mandal et al.
CELL STEM CELL (2014)
Conditional Knockouts Generated by Engineered CRISPR-Cas9 Endonuclease Reveal the Roles of Coronin in C. elegans Neural Development
Zhongfu Shen et al.
DEVELOPMENTAL CELL (2014)
Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex
Caryn R. Hale et al.
GENES & DEVELOPMENT (2014)
Efficient Marker-Free Recovery of Custom Genetic Modifications with CRISPR/Cas9 in Caenorhabditis elegans
Joshua A. Arribere et al.
GENETICS (2014)
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
Rajat M. Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
CRISPR/Cas9 and Genome Editing in Drosophila
Andrew R. Bassett et al.
JOURNAL OF GENETICS AND GENOMICS (2014)
Genome engineering with TALENs and ZFNs: Repair pathways and donor design
Dana Carroll et al.
METHODS (2014)
Optimization of Genome Engineering Approaches with the CRISPR/Cas9 System
Kai Li et al.
PLOS ONE (2014)
Heritable Genome Editing with CRISPR/Cas9 in the Silkworm, Bombyx mori
Wei Wei et al.
PLOS ONE (2014)
Implementation of the CRISPR-Cas9 system in fission yeast
Jake Z. Jacobs et al.
NATURE COMMUNICATIONS (2014)
Exciting Prospects for Precise Engineering of Caenorhabditis elegans Genomes with CRISPR/Cas9
Christian Frokjaer-Jensen
GENETICS (2013)
TALENs and ZFNs are associated with different mutation signatures
Yongsub Kim et al.
NATURE METHODS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
INNOVATION TALENs: a widely applicable technology for targeted genome editing
J. Keith Joung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly
Shijia Chen et al.
NUCLEIC ACIDS RESEARCH (2013)
The Non-homologous End-Joining (NHEJ) Pathway for the Repair of DNA Double-Strand Breaks: I. A Mathematical Model
Reza Taleei et al.
RADIATION RESEARCH (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Hirotaka Ebina et al.
SCIENTIFIC REPORTS (2013)
A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
James R. Tysome et al.
CLINICAL CANCER RESEARCH (2012)
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Giedrius Gasiunas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
RCC classification using miRNA signatures
Annette Fenner
Nature Reviews Urology (2011)
Targeted Genome Editing Across Species Using ZFNs and TALENs
Andrew J. Wood et al.
SCIENCE (2011)
Interaction of the Cas6 Riboendonuclease with CRISPR RNAs: Recognition and Cleavage
Ruiying Wang et al.
STRUCTURE (2011)
Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme
Sabrina Facchino et al.
Cancers (2011)
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
Luciano A. Marraffini et al.
NATURE REVIEWS GENETICS (2010)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
CRISPR-based adaptive and heritable immunity in prokaryotes
John van der Oost et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Share Paper
